According to the research report titled ‘Global Hormone Replacement Therapy Market 2021-2028‘, available with Market Study Report, global hormone replacement therapy market is slated to record a CAGR of 7.75% over 2021-2028.
 

As cited by the report, increasing awareness about health issues arising during menopause, prevalence of hormonal disorders, and innovative product launches by prominent players are catalyzing the growth of global hormone replacement therapy market. Moreover, launch of telemedicine clinical practice services is also fueling the industry expansion.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3855553/
 

Despite the positive outlook, high cost of hormonal treatments, coupled with adverse reactions pertaining to the therapy are likely to hamper the growth of the industry over the projected duration.
 

In terms of therapy type, the market sphere is classified into thyroid, estrogen, progestogen, testosterone, and human growth hormone replacement therapy, whereas based on disease type, the industry vertical is fragmented into hypothyroidism, growth hormone deficiency, male hypogonadism, menopause, and others. Speaking of route of administration, worldwide hormone replacement therapy market is divided into transdermal, parenteral, oral and others.
 

As per expert verbatim, North America, Europe, Middle East & Africa, Asia Pacific, and Latin America are major benefactors to the industry remuneration. Among these, Asia Pacific industry is poised to register momentous growth through 2028, accreditable to advancements in healthcare services for treatment of hormonal imbalance and menopausal disorders, surging elderly populace as well as soaring health awareness among the population base.
 

Leading companies in global hormone replacement therapy industry include Viatris Inc., Teva Pharmaceutical Industries Ltd., Pfizer Inc., Novo Nordisk A/S, Noven Pharmaceuticals Inc., Novartis International AG, Merck KGaA , Ipsen S.A., Genentech Inc., Eli Lilly and Company, Dr. Reddy's Laboratories Ltd., Bayer AG, ANI Pharmaceuticals Inc., Amgen Inc., and Abbott Laboratories among others.